"Jefferson City Medical Group is one of Missouri's largest multi-specialty groups. JCMG in Jefferson City, MO grew from the belief that the best medical decisions are made by patients working closely with their physicians. For medical advice, please call your physician."

During the past decade, Jefferson City Medical Group conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jefferson City Medical Group" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Celgene" with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Accentia Biopharmaceuticals" with 1 trials sponsored and "Ayala Pharmaceuticals, Inc," with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson City Medical Group" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Jefferson City Medical Group" are "Crohn Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Jefferson City Medical Group" in a lesser frequency.

Most popular intervention types in "Jefferson City Medical Group" are "Drug" (17 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (2 trials), "GED-0301" (2 trials), "vildagliptin" (2 trials) and "AL102" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jefferson City Medical Group" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Jefferson City Medical Group". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Jefferson City Medical Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Jefferson City Medical Group, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".